Transgene S.A.
TRGNF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $155,016 | $148,746 | $929 | $243,576 |
| - Cash | $16,670 | $15,666 | $4,403 | $5,911 |
| + Debt | $10,396 | $1,349 | $2,449 | $3,844 |
| Enterprise Value | $148,742 | $134,429 | -$1,025 | $241,509 |
| Revenue | $6,353 | $7,900 | $3,126 | $9,993 |
| % Growth | -19.6% | 152.7% | -68.7% | – |
| Gross Profit | -$27,925 | -$21,688 | -$29,042 | -$22,890 |
| % Margin | -439.6% | -274.5% | -929% | -229.1% |
| EBITDA | -$26,652 | -$28,440 | -$30,327 | -$23,550 |
| % Margin | -419.5% | -360% | -970.2% | -235.7% |
| Net Income | -$33,971 | -$22,328 | -$32,810 | -$20,004 |
| % Margin | -534.7% | -282.6% | -1,049.6% | -200.2% |
| EPS Diluted | -0.34 | -0.22 | -0.33 | -0.22 |
| % Growth | -54.5% | 33.3% | -50% | – |
| Operating Cash Flow | -$23,548 | -$34,671 | -$20,303 | -$31,943 |
| Capital Expenditures | -$3,075 | -$2,667 | -$1,535 | -$686 |
| Free Cash Flow | -$26,623 | -$37,417 | -$21,838 | -$32,629 |